Berberine Photo-Activation Potentiates Cytotoxicity in Human Astrocytoma Cells through Apoptosis Induction.
Photodynamic therapy (PDT) has recently attracted interest as an innovative and adjuvant treatment for different cancers including malignant gliomas. Among these, Glioblastoma (GBM) is the most prevalent neoplasm in the central nervous system. Despite conventional therapeutic approaches that include surgical removal, radiation, and chemotherapy, GBM is characterized by an extremely poor prognosis and a high rate of recurrence. PDT is a physical process that induces tumor cell death through the genesis and accumulation of reactive oxygen species (ROS) produced by light energy interaction with a photosensitizing agent. In this contribution, we explored the potentiality of the plant alkaloid berberine (BBR) as a photosensitizing and cytotoxic agent coupled with a PDT scheme using a blue light source in human established astrocytoma cell lines. Our data mainly indicated for the combined BBR-PDT scheme a potent activation of the apoptosis pathway, through a massive ROS production, a great extent of mitochondria depolarization, and the sub-sequent activation of caspases. Altogether, these results demonstrated that BBR is an efficient photosensitizer agent and that its association with PDT may be a potential anticancer strategy for high malignant gliomas.
['Carriero|Francesca|F|', 'Martinelli|Carolina|C|', 'Gabriele|Fabio|F|', 'Barbieri|Giulia|G|0000-0001-6622-5876', 'Zanoletti|Lisa|L|', 'Milanesi|Gloria|G|0000-0002-0454-1416', 'Casali|Claudio|C|', 'Azzalin|Alberto|A|0000-0001-6037-853X', 'Manai|Federico|F|', 'Paolillo|Mayra|M|0000-0002-7751-3336', 'Comincini|Sergio|S|0000-0001-7568-1144']
astrocytoma glial tumor oxidative stress phyto-therapy